Huatanjiangqi capsule regulates Nrf2/HDAC2 and improves glucocorticoid resistance of 16HBE cells
10.12092/j.issn.1009-2501.2021.12.004
- Author:
Mengwen WANG
1
;
Chongyang WANG
1
;
Fulin TAO
1
;
Wentao ZHU
1
;
Zhili HAN
1
;
Nianxia SUN
1
;
Dianlei WANG
1
;
Yan GUO
2
;
Zegeng LI
3
;
Dianlei WANG
4
Author Information
1. School of Pharmacy, Anhui University of Chinese Medicine
2. Department of Pharmacy, Fuyang Sixth People's Hospital
3. The First Afliated Hospital to Anhui University of Chinese Medicine
4. Anhui Province Key Laboratory of Research & Development of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Chronic obstructive pulmonary disease;
Glucocorticoid resistance;
Glutathione;
Histone deacetylase 2;
Huatanjiangqi capsule;
Nrf2
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(12):1360-1369
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To explore the effect of Huatanjiangqi capsule medicated serum (HTJQ) on the resistance of human bronchial epithelial cells (16HBE) to glucocorticoid (GC) stimulated by cigarette smoke extract (CSE). METHODS: After 16HBE cells were treated with HTJQ, the effects of different concentrations of HTJQ on the viability of 16HBE cells were determined by CCK-8 method. 16HBE cells were pretreated with HTJQ, and then cultured with dexamethasone (DEX) and lipopolysaccharide (LPS) for 24 hours, the effect of HTJQ on glucocorticoid (GC) resistance of 16HBE cells was determined by Enzyme-linked immunosorbent assay (ELISA). The effects of HTJQ, sulforaphane (SFN) and glutathione (GSH) on the expression of NF-E2-related factors 2 (Nrf2), Heme oxygenase-1 (HO-1) and histone deacetylase 2 (HDAC2) in 16HBE cells stimulated by CSE were measured by Western blot, and the effects of HTJQ, SFN and GSH on interleukin-8 (IL-8) in 16HBE cells were measured by ELISA. RESULTS: HTJQ promoted the proliferation of 16HBE cells at 1 h, 2 h and 4 h, the results of ELISA and Western blot showed that CSE induced GC resistance and decreased the expression of Nrf2, HO-1 and HDAC2 in 16HBE cells, HTJQ significantly decreased IL-8 and improved GC sensitivity of 16HBE cells (P<0.01), and up-regulated the expression of Nrf2, HO-1 and HDAC2 (P<0.01). In addition, HTJQ significantly up-regulated the level of GSH in 16HBE cells (P<0.01). Nrf2 agonists SFN and GSH significantly improved the glucocorticoid sensitivity of 16HBE cells (P<0.01), and up-regulated the expression of Nrf2, HO-1 and HDAC2 (P<0.01). CONCLUSION: HTJQ improves the GC resistance of 16HBE cells by up-regulating the expression of Nrf2/HDAC2 protein and the level of intracellular GSH.
